Endocrine, reproductive, and cardiovascular drugs

 
Endocrine, Reproductive, and Cardiovascular Drugs
Complete the following and submit your answers.
·         Chapter 23, page 470, Case Study B- Antidiabetic Agents and page 471, questions 1 through 10.
·         Chapter 25, page 494, questions 1 through 10.
Chapter 23, page 470, Case Study B – Antidiabetic Drugs
1.      The physician starts him on glyburide, a sulfonylurea medication.  He explains to Marcus that sulfonylureas work by:
2.      The physician explains to Marcus that one of the side effects of a sulfonylurea medication is:
3.      Prior to prescribing the medication, the physician reviews Marcus’s medical history.  This is because sulfonylureas must be used with extreme caution in individual’s who:
4.      The physician cautions Marcus to call him prior to taking any other medication because of possible interactions.  Which drug can potentiate the hypoglycemic effect of a sulfonylurea?
5.      What drug causes an interaction with sulfonylureas, resulting in antagonistic action in which a larger dose may be required?
Antidiabetic Agents and page 471, questions 1 through 10.
1.      Glucophage – Oral antidiabetic agent
2.      prednisone – Corticosteroid
3.      Humulin R – Insulin: short acting
4.      Synthroid – Thyroid agent
5.      Avandia – Oral antidiabetic agent
6.      Tapazole – Antithyroid
7.      Isophane – Insulin: intermediate acting
8.      Prandin – Oral antidiabetic agent
9.      Lantus – Insulin: long acting
10.  Humalog – Insulin: rapid acting
Chapter 25, page 494 (actually pg. 541), questions 1 through 10
1.      isosorbide – Angina
2.      Zetia – Elevated cholesterol
3.      Lovenox – Pulmonary emboli
4.      Cardizem – Hypertension
5.      Zocor – Elevated cholesterol
6.      Plavix – Stroke prevention (platelet inhibitor)
7.      Crestor – Elevated cholesterol
8.      hydralazine – Hypertension
9.      quinidine – Cardiac arrhythmia
10.  procainamide – Cardiac arrhythmia